Position in PVLA
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$68,616
+$12,649 QoQ
Shares Held
449
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#154
of 197 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Archer Investment Corp holds $770,226 across 19 Biotechnology names. PVLA ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
830 | $308,486 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
17,401 | $80,740 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,000 | $78,270 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
This page
|
449 | $68,616 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
5,872 | $51,409 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
600 | $47,574 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
500 | $40,755 | |
| 8 | MRNA |
Moderna, Inc.
|
520 | $36,415 |
All Filings in PVLA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,616 | 449 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $55,967 | 449 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $46,996 | 449 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $28,147 | 449 | Shares | Sole | 2025-11-03 | |
| No filing history on record for this holder in this stock. | ||||||